Full-Time
Distribution Specialist 2
Alphatec Spine
1,001-5,000 employees
Develops and markets spinal surgery solutions
Compensation Overview
$20.50 - $22.75/hr
Carlsbad, CA, USA
In Person
 Warehouse & Fulfillment (1) |
|---|
Get referred to Alphatec Spine
See people who can refer or advise you
- Basic proficiency with Microsoft Office software.
- Proficiency in the designated area.
- Ability to perform a mix of basic and more specialized tasks.
- Experience with document management software and ability to navigate the Internet.
- Interpersonal and communication skills, both verbal and written.
- Typically requires less than one year of related experience; a high school diploma or equivalent is required.
- A minimum of two years of experience.
- For United States roles requiring access to hospital facilities, eligibility to obtain and maintain credentials at all required hospitals, including meeting applicable physical or vaccination requirements, including the COVID-19 vaccine when applicable.
- Initiate, maintain, and compile records associated with ordering, receiving, storing, issuing, and shipping materials, supplies, and equipment.
- Package and prepare products and merchandise for final shipment, post weights and shipping charges, and prepare and maintain records of merchandise shipped.
- Review customer orders; examine, stock, and distribute merchandise, products, and materials in the distribution center.
- Compare nomenclature, stock numbers, and other listed information on packing slips to verify purchase orders and shipping orders.
- Compile and perform data-entry tasks to maintain inventory, purchasing, shipping, and other records.
- Use contracts, purchase orders, invoices, requisitions, and other data sources to verify inventory computations against physical stock counts; adjust errors and document discrepancies with proposed corrective action.
- Maintain manual or computerized records, including material inventory, in-process production reports, and material-location status.
- Compile information on the receipt or disbursement of material, equipment, merchandise, or supplies, and compute inventory balance, price, and cost.
- Package materials and equipment, ensuring shipping documentation is accurate and materials are adequately protected for shipment.
- Determine the most efficient and economical routing and mode of transportation.
- Initiate investigations into causes of misdirected shipments, shipment damage or shortages, and freight-cost overcharges.
- Assist with or perform other related tasks as assigned.
Alphatec Spine develops and sells implants, instruments, and integrated technologies for spine surgery, including devices used in fusion procedures and related navigation or imaging systems gained through acquisitions like SafeOp Surgical. During surgery, surgeons use these implants and instruments, often with imaging or navigation tools to plan and guide the procedure, while the implants support fusion and healing. It differentiates itself with a broad product portfolio and enhanced technology through strategic acquisitions, giving it capabilities in navigation and advanced spine solutions beyond a narrow line of implants. Its goal is to improve spinal surgery outcomes and expand access to effective spine-care solutions.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Carlsbad, California
Founded
1990
Get referred to Alphatec Spine
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 revenue reached $214 million, up 15%, with surgical revenue up 17%.
- Adjusted EBITDA hit $36 million, and Alphatec raised 2026 guidance to $140 million.
- Management expects at least $20 million free cash flow and continued full-year growth.
What critics are saying
- EOS revenue missed Q1 2026 expectations, triggering a 32% share drop May 5.
- Kirby McInerney and Ademi investigations target Alphatec's May 2026 disclosures.
- Persistent EOS installation failures would destroy surgeon trust and compress valuation through 2027.
What makes Alphatec Spine unique
- EOS imaging, navigation, and implants bundle spine surgery workflows into one platform.
- Q2 2026 net new surgeon users rose 24%, showing sticky clinical adoption.
- The 2031 bank facility supports scaling without near-term refinancing distractions.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Paid Vacation
Paid Sick Leave
Paid Holidays
Disability Insurance
Stock Options
Growth & Insights and Company News
6 month growth
↑ 4%1 year growth
↑ 4%2 year growth
↑ 4%Alphatec Holdings reported strong Q2 2026 results with total revenue of $214 million, up 15% year-over-year, and surgical revenue of $196 million, up 17%. The medical device company saw adjusted EBITDA rise 53% to $36 million, with margins expanding 420 basis points to 17%. The company added 24% more net new surgeons and posted 20% case volume growth. Gross margin improved 260 basis points to 72.5%, driven by better inventory efficiency and favourable product mix. Alphatec generated positive free cash flow of approximately $1 million in Q2 and raised full-year adjusted EBITDA guidance to $140 million from $134 million previously. However, revenue per case declined 2.7% due to case mix shifts and international growth. The company now expects full-year revenue per case to decline in the low single digits, citing slower biologics attachment improvement.
Alphatec, a spine surgery technology company, reported revenue of $764.2 million in FY 2025, up 25% year-over-year, but posted a net loss of $143.4 million. The company's debt-to-equity ratio stands at approximately 17.2x, whilst its current ratio is 2.1x. Stock-based compensation represented roughly 163% of operating cash flow. Inspire Medical Systems specialises in neurostimulation therapy for obstructive sleep apnea patients who cannot use standard breathing machines. The company targets sleep specialists and ENT surgeons globally. Alphatec differentiates itself through an integrated ecosystem using subsidiaries like EOS imaging and SafeOp Surgical, serving primarily the US hospital market whilst expanding into Europe and Japan. Both companies operate in medical technology but represent different maturity levels and financial profiles for investors seeking healthcare device exposure.
Alphatec Holdings, a medical technology company specialising in spinal surgery solutions, reported strong first-quarter 2026 results with surgical revenue up 17% and total revenue growing 14% to $192 million. The company achieved non-GAAP adjusted EBITDA of $21 million whilst securing a new bank facility that reduces annual interest expenses by over $6 million. Growth was driven by a 21% increase in surgical case volume and 23% rise in net new surgeon users. The company reported an ending cash balance of $140 million and trailing twelve-month free cash flow of $7 million. For full-year 2026, Alphatec expects total revenue of approximately $882 million, representing 15% growth, with adjusted EBITDA projected at $134 million and at least $20 million in free cash flow generation.
Kirby McInerney LLP is investigating potential securities law violations by Alphatec Holdings and its senior management following a sharp share price decline. On 5 May 2026, Alphatec reported first quarter revenue of $192 million and disclosed that EOS revenue, from its proprietary imaging platform, was $14 million—below internal expectations. The company reduced its full-year 2026 EOS revenue guidance to approximately $77 million from $85 million, citing execution issues with equipment installations. Management stated that "installation timing was a challenge" and the company failed to fulfill committed units. Following the announcement, Alphatec shares fell 32%, from $10.23 to $6.99 per share. No lawsuit has been filed yet, and the investigation is ongoing to determine whether claims may be brought under federal securities laws.
Alphatec Holdings shares fell 25% to $6.99 following its first-quarter results, which showed revenue of $192 million, falling 2.3% short of analyst estimates. Statutory losses of $0.22 per share were 12% smaller than expected. Following the results, eleven analysts revised their forecasts, maintaining revenue expectations of $881.8 million for 2026, representing 12% growth. They improved loss predictions to $0.52 per share, down from $0.55 previously. However, the average price target fell 26% to $18.00, with individual targets ranging from $11.00 to $25.00. Analysts expect Alphatec Holdings' revenue growth to slow to 16% annually through 2026, down from 28% over the past five years, though this remains above the industry average of 8%.